The patent covering Cytovac’s platform technology, ALECSAT, has been granted in all important regions like Europe, US, Japan and in addition in Australia and Singapore. Besides covering the technology and the manufacturing process the granted patents also cover second medical use or method of treatment. In the US, one divisional application covering method of treatment is pending.

Error, cant find that post.